Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

June 7, 2026

Press Releases - Lifestyle

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

June 7, 2026

Press Releases - Lifestyle

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

June 7, 2026

Press Releases - Lifestyle

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

June 7, 2026

Press Releases - Lifestyle

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

June 7, 2026

Press Releases - Lifestyle

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

June 7, 2026

Press Releases - Lifestyle

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

June 7, 2026

Press Releases - Lifestyle

RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit

June 7, 2026

Press Releases - Lifestyle

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

June 7, 2026

Press Releases - Food & Drink

Soules Kitchen Declares June 7th (6/7) the Official Day of Delightful Dinners

June 7, 2026

Page 777 of 3688 Prev 1 … 776 777 778 … 3,688 Next

No Result

View All Result

Home

Cision PR Newswire

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

Soules Kitchen Declares June 7th (6/7) the Official Day of Delightful Dinners

Recommended

New Epic Artificial Intelligence Tool Transforms the Health Care Experience

Hampton Capital Founder John Priest on Why Structural Shifts–Not Revenue Growth–Drive Enterprise Value

Popular News

Best Reading Glasses for Women (2026): EZContacts Recognized for Style, Comfort, and Value by Expert Consumers

Driive Launches Dot, a Virtual Scheduler Built on a Real Scheduling Brain, Not Just Another Voice AI Answering Service

13 Press Releases You Need to See This Week Including the returns of never-ending pasta at Olive Garden and popcorn chicken at KFC, new seat options from United Airlines, and a partnership between 3M and Microsoft.

Aurra Markets Named ‘Top Low Spread Forex Broker 2026’ at Money Expo Abu Dhabi

RiskSpan Launches Credit Model 7.1, a Purpose-Built NonQM Credit Model Inside the RiskSpan Platform

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands